Medical Device Adapted To Detect Disengagement Of A Transcutaneous Device

• US 20080167641A1
• Filed: 05/15/2006
• Published: 07/10/2008
• Est. Priority Date: 05/13/2005
• Status: Abandoned Application

• Current Assignee: Novo Nordisk A/S
• Original Assignee: Novo Nordisk A/S
• Inventors: Bengtsson, Henrik, Hansen, Steffen, Nielsen, Ole Christian, Jensen, Jens Peter
• Application Number:
  US11/913,689
• Publication Number:
  US 20080167641A1
• Time in Patent Office: Days
• US Class Current: 604/891.1
• CPC Class Codes: A61M 2005/14252 with needle insertion means
• CPC Class Codes: A61M 2205/13 with means for the detection of operative contact with patient, e.g. lip sensor
• CPC Class Codes: A61M 5/14248 of the skin patch type
• CPC Class Codes: A61M 5/16836 by sensing tissue properties at the infusion site, e.g. for detecting infiltration detecting tissue temperature for diagnostic purposes A61M39/0247
• CPC Class Codes: A61M 5/46 having means for controlling depth of insertion
• CPC Class Codes: G16H 20/17 delivered via infusion or injection
• CPC Class Codes: G16H 40/63 for local operation

Abstract

The present invention provides a medical device comprising a transcutaneous device. The medical device further comprises a controller for detecting a first condition representative of the transcutaneous device being arranged in a subcutaneous first position, and for detecting a second condition representative of the transcutaneous device being arranged in a non-subcutaneous second position, wherein the controller is adapted for actuating an alarm when a condition representative of the transcutaneous device being arranged in a non-sub-cutaneous position is detected.

Claims

1. A drug delivery device (300, 600, 700, 1000) comprising, or being adapted to be connected to, a transcutaneous access device (951, 630, 730) adapted to be arranged subcutaneously in a subject, the drug delivery device further comprising:

a reservoir (350, 620, 720) adapted to contain a fluid drug,

an expelling assembly (330, 640, 740) adapted for cooperation with the reservoir to expel fluid drug out of the reservoir and through the transcutaneous access device,

a controller (361, 650, 750) for detecting a first condition representative of the transcutaneous access device being arranged in a subcutaneous first position, and for detecting a second condition representative of the transcutaneous access device being arranged in a non-subcutaneous second position, wherein

the controller is adapted for performing an action corresponding to the detection of the second condition.

2. A drug delivery device as in claim 1, wherein the controller is adapted to:

operate the expelling assembly in accordance with a first mode,

detect a value for a property associated with operation of the expelling assembly,

provide a first value range when the expelling assembly is operated during the first mode, the first value range being indicative of a first condition of delivery of drug,

on the basis of the first value range provide a second value range, the second value range being indicative of a second condition of delivery of drug,

operate the expelling assembly in accordance with a second mode,

detect a value for the property when the expelling assembly is operated during the second mode, and

perform an action when a detected value is within the second value range.

3. A drug delivery device as in claim 2, wherein the first mode is priming of the pump and the transcutaneous access device with fluid drug, and the first condition is subcutaneous delivery of drug when the transcutaneous access device is arranged subcutaneously, and the second condition is non-subcutaneous delivery of drug.

4. A drug delivery device as in claim 1, wherein the controller is adapted to detect a first condition associated with the subcutaneous delivery of drug, and detect a second condition associated with the non-subcutaneous delivery of drug.

5. A drug delivery device as in claim 4, wherein the controller is adapted to detect a first condition associated with the pressure in the transcutaneous access device during subcutaneous delivery of drug, and to detect a second condition associated with the pressure in the transcutaneous access device during non-subcutaneous delivery of drug.

6. A drug delivery device as in claim 4, wherein the controller is adapted to detect a first condition associated with a first pressure in the transcutaneous access device during delivery of drug, and to detect a second condition associated with a lower pressure in the transcutaneous access device during delivery of drug.

7. A drug delivery device as in claim 2, wherein the controller comprises a pressure sensor (652) in fluid communication with the transcutaneous access device.

8. A drug delivery device as in claim 7, wherein the controller comprises information representing a first pressure range or pressure pattern associated with the first condition, and a second pressure range or pressure pattern associated with the second condition.

9. A drug delivery device as in claim 2, wherein the controller comprises a current sensor for sensing current supplied to the expelling assembly.

10. A drug delivery device as in claim 9, wherein the controller comprises information representing a first current range or current pattern associated with the first condition, and a second current range or current pattern associated with the second condition.

11. A drug delivery device as in claim 2, wherein the controller comprises a position sensor (528, 529, 537, 651) for sensing a position of a structure moved during operation of the expelling assembly.

12. A drug delivery device as in claim 11, wherein the expelling assembly comprises actuating means (500) moveable between first and second positions, the controller comprising detection means for detecting a lapsed time or time pattern when the actuating means is moved between the first and second positions in a given direction.

13. A drug delivery device as in claim 12, wherein the controller comprises information representing a first lapsed time range or time pattern associated with the first condition, and a second lapsed time range or time pattern associated with the second condition.

14. A drug delivery device as in claim 1, wherein the transcutaneous access device comprises or is associated with a sensor (806, 814, 825, 834, 845) influenced by a property associated with subcutaneous placement of a distal portion thereof.

15. A drug delivery device as in claim 1, further comprising a mounting surface (1020) adapted for application to a skin surface of the subject, wherein the transcutaneous access device comprises a distal end (951) adapted to be inserted through the skin of the subject, the distal end being moveable between an initial position in which the distal end is retracted relative to the mounting surface, and an extended position in which the distal end projects relative to the mounting surface.

16. A drug delivery device as in claim 1, further comprising a housing in which the reservoir and expelling assembly are at least partially arranged, the transcutaneous access device (731) being arranged outside the housing and being connected or connectable thereto by means of a flexible tube (732).

17. A drug delivery device as in claim 1, wherein the controller is adapted for actuating an alarm when a condition representative of the transcutaneous access device being arranged in a non-subcutaneous position is detected.

18. A drug delivery device as in claim 17, comprising indication means (771) adapted to indicate to a user that the transcutaneous access device is arranged in a non-subcutaneous position.

19. A drug delivery device as in claim 17, comprising a delivery unit (710) in which the reservoir and expelling assembly are arranged, and a remote unit (770) comprising indication means (771) adapted to indicate to a user that the transcutaneous access device is arranged in a non-subcutaneous position.

27. A computer usable media including an embedded computer program that is capable of carrying out a method as in claim 19 when the computer is executed in a drug delivery device comprising a transcutaneous access device adapted to be arranged subcutaneously in a subject, a reservoir adapted to contain a fluid drug, an expelling assembly adapted for cooperation with the reservoir to expel fluid drug out of the reservoir and through the transcutaneous access device, and a controller adapted to detect a condition influenced by the subcutaneous or non-subcutaneous position of the transcutaneous access device.

20. A method for operating a drug delivery device comprising a reservoir, an expelling assembly and a transcutaneous access device, comprising the steps of:

arranging the transcutaneous access device subcutaneously in a subject,

operating the expelling assembly to expel fluid drug out of the reservoir and through the transcutaneous access device,

detecting a property associated with operation of the expelling assembly,

determining a first value or range for the property with the transcutaneous access device arranged subcutaneously,

determining on the basis of the first value or range a second range indicative of the transcutaneous access device being arranged non-subcutaneously,

performing an action when a value or pattern for the property within the second range is detected during operation of the expelling assembly.

23. A method as in claim 20, wherein the property is representative of the pressure in the transcutaneous access device during operation of the expelling assembly.

25. A method as in claim 20, comprising the step of indicating to a user that the transcutaneous access device is arranged in a non-subcutaneous position.

21. A method for operating a drug delivery device comprising a reservoir, an expelling assembly and a transcutaneous access device, comprising the steps of:

operating the expelling assembly to expel fluid drug out of the reservoir through the transcutaneous access device,

detecting a property associated with operation of the expelling assembly,

determining whether the detected property is indicative of drug being expelled subcutaneously in a subject or non-subcutaneously.

22. A method for operating a drug delivery device comprising a reservoir, an expelling assembly and a transcutaneous access device, comprising the steps of:

arranging the transcutaneous access device subcutaneously in a subject,

operating the expelling assembly to expel fluid drug out of the reservoir and through the transcutaneous access device,

detecting a property associated with operation of the expelling assembly,

determining whether the detected property is indicative of drug being expelled subcutaneously in a subject or non-subcutaneously.

24. A method for operating a drug delivery device comprising a reservoir, an expelling assembly and a transcutaneous access device, comprising the steps of:

operating the expelling assembly to expel fluid drug out of the reservoir through the transcutaneous access device,

detecting a condition associated with the pressure in the transcutaneous access device during delivery of drug,

actuating an alarm when the detected condition is associated with a pressure below a defined value.

26. A method for operating a drug delivery device comprising a transcutaneous access device, comprising the steps of:

arranging the transcutaneous access device subcutaneously in a subject,

detecting a condition influenced by the transcutaneous access device being arranged in a subcutaneous or non-subcutaneous position, and

generating an alarm when a condition indicative of the transcutaneous access device being arranged in a non-subcutaneous position is detected.

28. A medical device (1000), comprising:

a transcutaneous device (951, 801, 811, 821, 831, 841, 851, 861) adapted to be arranged subcutaneously in a subject,

a controller (361, 802, 812, 822, 832, 842, 852, 862) for detecting a first condition representative of the transcutaneous device being arranged in a subcutaneous first position, and for detecting a second condition representative of the transcutaneous device being arranged in a non-subcutaneous second position, wherein

the controller is adapted for performing an action corresponding to the detection of the second condition.

29. A medical device as in claim 28, wherein the controller is adapted to:

operate the device in accordance with a first mode,

detect a value for a property associated with the first mode and provide a first value range being indicative of a first condition,

on the basis of the first value range provide a second value range, the second value range being indicative of a second condition,

operate the device in accordance with a second mode and detect a value for the property when the device is operated during the second mode, and

perform an action when a detected value is within the second value range.

30. A medical device as in claim 29, wherein the first mode is associated with the initial operation of the transcutaneous device, the first condition is associated with the transcutaneous device being arranged subcutaneously, and the second condition is associated with non-subcutaneous placement of the transcutaneous device.

31. A medical device, comprising:

a mounting surface (1020) adapted for application towards a skin surface of a subject,

a flexible transcutaneous device (871) comprising a distal portion adapted to be arranged subcutaneously in the subject through a point of insertion,

wherein the distal portion comprises a visual marking (873),

whereby the distal portion is readily identifiable by the naked eye of a user should the transcutaneous device disengage from its intended subcutaneous position.

32. A medical device as in claim 31, wherein the visual marking is in the form of a colour marking (873) arranged at the distal end of the transcutaneous device, or the visual marking is arranged along the length of the distal portion of the transcutaneous device.

33. A medical device as in claim 31, wherein, in a situation of use in which the medical device is applied towards the skin surface of the subject, the point of insertion can be observed directly by the user, this allowing the user to detect a condition in which the transcutaneous device has disengaged from its intended subcutaneous position.

34. A medical device as in claim 31, wherein the distal portion of the transcutaneous device (951) is moveable from a retracted position to an extended position relative to the mounting surface.

35. A medical device, comprising:

a mounting surface adapted for application towards a skin surface of a subject,

a first electrode (806) and a second electrode (805), and

means (802) for detecting a capacitance between the first and second electrodes,

wherein the first electrode is in the form of a transcutaneous device (801) comprising a distal portion adapted to be arranged subcutaneously in the subject, the transcutaneous device being conductive in a situation of use, and

wherein the second electrode is in the form of a skin-mountable electrode.

36. A medical device as in claim 35, wherein the transcutaneous device is conductive.

37. A medical device as in any of claims 35, wherein the transcutaneous device is hollow and substantially non-conductive, the fluid-filled transcutaneous device providing a conductive transcutaneous device in a situation of use.

38. A medical device as in claim 35, further comprising:

means (808) for applying an AC voltage between the two electrodes,

a controller for detecting a first condition determined by a first range of capacitance values representative of the transcutaneous access device being arranged in a subcutaneous first position, and for detecting a second condition determined by a second range of capacitance values representative of the transcutaneous access device being arranged in a non-subcutaneous second position, wherein

the controller is adapted for performing an action corresponding to the detection of the second condition.

39. A medical device as in claim 38, wherein the controller is adapted to:

detect a capacitance value when the medical device is operated during a first mode,

on the basis of the detected capacitance value provide a first capacitance value range, the first capacitance value range being indicative of a first condition of placement of the transcutaneous device,

on the basis of the first value range provide a second capacitance value range, the second value range being indicative of a second condition of placement of the transcutaneous device,

operate the medical device in accordance with a second mode,

detect a capacitance value when the medical device is operated during the second mode, and

perform an action when a detected capacitance value is within the second value range.

40. A medical device as in claim 39, wherein the first mode is an initial mode associated with the transcutaneous access device being arranged subcutaneously in the subject, the first condition is associated with the transcutaneous device being arranged subcutaneously with the second electrode in contact with the skin surface, and the second condition is associated with the transcutaneous device being arranged non-subcutaneously with second electrode in contact with the skin surface.

41. A medical device as in claim 35, wherein the second electrode is associated with the mounting surface.